A Prospective, Open Label Study of CERtican in KIdney Transplantation (CERKI)

Share this content:
A Prospective, Open Label Study of CERtican in KIdney Transplantation (CERKI)

Sponsors and Collaborators
Novartis Pharmaceuticals

Contact
Study Director
862-778-8300

ClinicalTrials.gov Identifier
NCT01594268

You must be a registered member of Renal and Urology News to post a comment.

Sign Up for Free e-newsletters